How do I subscribe to ongoing alerts?

Subscribe to /feed/company/yangtze-river-pharmaceutical-group-jiangsu-zilong-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ornidazole and Sodium Chloride Injection	Ornidazole and Sodium Chloride Injection	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA	Infectious Disease
Levornidazole Disodium Phosphate for Injection	Levornidazole Disodium Phosphate for Injection	marketed	Nitroimidazole antibiotic	Microbial DNA (non-selective; requires anaerobic reduction)	Infectious Disease

Therapeutic area mix

Infectious Disease · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Appili Therapeutics Inc. · 1 shared drug class
Balmoral Medical company · 1 shared drug class
Dongfang Hospital Beijing University of Chinese Medicine · 1 shared drug class
Johns Hopkins Bloomberg School of Public Health · 1 shared drug class
LEO Pharma · 1 shared drug class
National Taiwan University Hospital · 1 shared drug class
Sherief Abd-Elsalam · 1 shared drug class
University of Alabama at Birmingham · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd:

Cite this brief

Drug Landscape (2026). Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/yangtze-river-pharmaceutical-group-jiangsu-zilong-pharmaceutical-co-ltd. Accessed 2026-05-17.